1 |
Donovan J, Brown P. 2006. Blood collection. Curr. Protoc. Immunol. DOI: 10.1002/0471142735.im0107a73.
|
2 |
Arnold LJJ, Dagan A, Gutheil J, Kaplan NO. 1979. Antineoplastic activity of poly(L-lysine) with some ascites tumor cells. Proc. Natl. Acad. Sci. USA 76: 3246-3250.
DOI
ScienceOn
|
3 |
Bae Y, Fukushima S, Harada A, Kataoka K. 2003. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. Engl. 42: 4640-4643.
DOI
ScienceOn
|
4 |
De Vries A, Feldman JD, Stein O, Stein Y, Katchalski E. 1953. Effects of intravenously administered poly-DL-lysine in rats. Proc. Soc. Exp. Biol. Med. 76: 237-240.
|
5 |
Harada-Shiba M, Yamauchi K, Harada A, Takamisawa I, Shimokado K, Kataoka K. 2002. Polyion complex micelles as vectors in gene therapy - pharmacokinetics and in vivo gene transfer. Gene Ther. 9: 407-414.
DOI
ScienceOn
|
6 |
Hatton MW, Regoeczi E. 1975. The relevance of the structure of lysine bound to Sepharose for the affinity of rabbit plasminogen. Biochim. Biophys. Acta 379: 504-511.
DOI
ScienceOn
|
7 |
Jackson KS, Yeom J, Han Y, Bae Y, Ryou C. 2013. Preference toward a polylysine enantiomer in inhibiting prions. Amino Acids 44: 993-1000.
DOI
ScienceOn
|
8 |
Johnston TP, Kuchimanchi KR, Alur H, Chittchang M, Mitra AK. 2003. Inducing a change in the pharmacokinetics and biodistribution of poly-L-lysine in rats by complexation with heparin. J. Pharm. Pharmacol. 55: 1083-1090.
DOI
ScienceOn
|
9 |
Langeland N, Moore LJ, Holmsen H, Haarr L. 1988. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J. Gen. Virol. 69: 1137-1145.
DOI
ScienceOn
|
10 |
Nicholas Delihas LWR, Loo W, Berkowitz J, Poltoratskaia N. 1995. High sensitivity of mycobacterium species to the bactericidal activity by polylysine. FEMS Microbiol. Lett. 132: 233-237.
DOI
ScienceOn
|
11 |
Mays CE, Ryou C. 2010. Plasminogen stimulates propagation of protease-resistant prion protein in vitro. FASEB J. 24: 5102-5112.
DOI
ScienceOn
|
12 |
Mays CE, Ryou C. 2011. Plasminogen: A cellular protein cofactor for PrPSc propagation. Prion 5: 22-27.
DOI
|
13 |
Moreau E, Domurado M, Chapon P, Vert M, Domurado D. 2002. Biocompatibility of polycations: In vitro agglutination and lysis of red blood cells and in vivo toxicity. J. Drug Target. 10: 161-173.
DOI
|
14 |
Okuda T, Kawakami S, Maeie T, Niidome T, Yamashita F, Hashida M. 2006. Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. J. Control. Release 114: 69-77.
DOI
ScienceOn
|
15 |
Park SH, Raines RT. 2004. Fluorescence gel retardation assay to detect protein-protein interactions. Methods Mol. Biol. 261: 155-160.
|
16 |
Ryou C. 2010. Transmissible spongiform encephalopathy, pp. 151-172. In Saleh M (ed.). Molecular Aspects of Infectious Diseases. Nova Science Publisher, Hauppauge, New York.
|
17 |
Ryou C. 2011. Prion diseases. In Harper D (ed.). Encyclopedia of Life Sciences. John Wiley & Sons Inc, Chichester, UK.
|
18 |
Ryou C, Titlow WB, Mays CE, Bae Y, Kim S. 2011. The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion. Biomaterials 32: 3141-3149.
DOI
ScienceOn
|
19 |
Sakharov DV, Jie AFH, Bekkers MEA, Emeis JJ, Rijken DC. 2001. Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and longterm retention within the vascular wall. Arterioscler. Thromb. Vasc. Biol. 21: 943-948.
DOI
ScienceOn
|
20 |
Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LAJ, et al. 2007. Resolution of inflammation: State of the art, definitions and terms. FASEB J. 21: 325-332.
DOI
ScienceOn
|
21 |
Schmaier AH, Lazarus HM. 2011. Acquired thrombocytopenia, pp. 154-173. In Warkentin TE, Warkentin AE (eds.). Concise Guide to Hematology. Wiley-Blackwell.
|
22 |
Sela M, Katchalski E. 1959. Biological properties of poly-aamino acids, pp. 391-478. In Anfinsen CB, et al. (eds.). Advances in Protein Chemistry, Vol. 14. Academic Press, New York.
|
23 |
Sodetz JM, Brockway WJ, Castellino FJ. 1972. Multiplicity of rabbit plasminogen. Physical characterization. Biochemistry 11: 4451-4458.
|
24 |
Ward CM, Read ML, Seymour LW. 2001. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 97: 2221-2229.
DOI
ScienceOn
|
25 |
Xu Z, Adrover M, Pastore A, Prigent S, Mouthon F, Comoy E, et al. 2011. Mechanistic insights into cellular alteration of prion by poly-D-lysine: The role of H2H3 domain. FASEB J. 25: 3426-3435.
DOI
ScienceOn
|